Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor.
Front Endocrinol (Lausanne). 2021 Oct 20;12:740913. doi: 10.3389/fendo.2021.740913. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 34745007
Free PMC article.